Zoetis Inc.

(New York Stock Exchange)
Back to all articles
Slightly Bullish +25

Zoetis Declares Third-Quarter 2026 Cash Dividend

AI-generated analysis

πŸ“… Zoetis Inc. (ZTS) declared a third-quarter 2026 cash dividend of $0.53 per share on May 20, 2026.

πŸ’° The dividend is scheduled to be paid on September 1, 2026, to shareholders of record as of July 20, 2026.

🀝 This payout reflects the company's commitment to returning capital and demonstrates confidence in its financial position.

πŸ“ˆ Analysts maintain a Buy rating on ZTS with an average price target of $112.00.

βš–οΈ TipRanks' AI Analyst Spark rates ZTS as Neutral due to strong profitability offset by weak technicals and mixed earnings commentary.

🐾 Zoetis faces positive full-year guidance and strong international execution but contends with weakness in the U.S. companion-animal sector.

🌍 The company operates in over 100 countries, serving veterinarians, livestock producers, and pet owners with medicines, vaccines, and diagnostics.

🏒 Listed on the NYSE as ZTS, Zoetis is the world's leading animal health company with nearly 75 years of experience.

πŸ“Š The dividend decision underscores income visibility for investors and highlights the company's cash generation capacity.

⚠️ Valuation is considered supportive but not compelling enough to outweigh near-term demand risks according to Spark's analysis.

Bullish Signals
  • Zoetis declared a third-quarter 2026 cash dividend of $0.53 per share, demonstrating confidence in its financial position and cash generation capacity.
  • The company's ongoing commitment to returning capital to shareholders through regular dividends provides income visibility for investors.
  • Analysts maintain a Buy rating on ZTS with a price target of $112.00, reflecting strong underlying profitability and cash generation.
  • Zoetis is the world's leading animal health company operating in more than 100 countries, leveraging data-driven R&D and advanced manufacturing.
Risk Factors
  • Analyst commentary notes meaningful weakness in U.S. companion-animal sales, which offsets strong performance elsewhere.
  • Competitive uncertainty is explicitly cited as a factor holding back the stock's technicals and near-term demand outlook.
  • Weak technical indicators show the price trading well below key moving averages with negative momentum.
Full Analysis
Zoetis Inc. (ZTS) declared a third-quarter 2026 cash dividend of $0.53 per share on May 20, 2026. The dividend is scheduled to be paid on September 1, 2026, to shareholders of record as of the close of business on July 20, 2026. This decision highlights Zoetis's commitment to returning capital to shareholders and reflects confidence in its financial position and cash generation capabilities. Analyst ratings for ZTS stock show a Buy rating with a $112.00 price target, while TipRanks' AI Analyst gives it a Neutral score due to strong profitability offset by weak technicals and mixed earnings commentary. Zoetis is the world's leading animal health company focused on advancing care for animals, providing medicines, vaccines, diagnostics, biopharmaceuticals, and digital solutions to veterinarians, livestock producers, and pet owners in more than 100 countries.